Codice QR

Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease

Background No large‐scale study has compared the clinical impact of triple antiplatelet therapy (TAPT: aspirin, clopidogrel, and cilostazol) and dual antiplatelet therapy (DAPT) on adverse limb events in patients with diabetes after endovascular therapy (EVT) for peripheral artery disease. Thus, we...

Descrizione completa

Salvato in:
Autori principali: Jung‐Joon Cha, Jae Young Cho, Subin Lim, Ju Hyeon Kim, Hyung Joon Joo, Jae Hyoung Park, Soon Jun Hong, Do‐Sun Lim, Hyungdon Kook, Seung Hun Lee, Young‐Guk Ko, Pil‐Ki Min, Jae‐Hwan Lee, Chang‐Hwan Yoon, In‐Ho Chae, Seung Whan Lee, Sang‐Rok Lee, Seung Hyuk Choi, Yoon Seok Koh, Cheol Woong Yu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley 2023-06-01
Serie:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:
cilostazol
critical limb ischemia
diabetes
peripheral artery disease
triple antiplatelet therapy
Accesso online:https://www.ahajournals.org/doi/10.1161/JAHA.122.027334
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi